Skip to main content
CVS GROUP PLC logo

CVS GROUP PLC — Investor Relations & Filings

Ticker · CVSG ISIN · GB00B2863827 LEI · 213800J41XDQ2NX48O05 IL Professional, scientific and technical activities
Open in API
Filings indexed 790 across all filing types
Latest filing 2022-07-28 Earnings Release
Country GB United Kingdom
Listing IL CVSG

About CVS GROUP PLC

https://www.cvsuk.com/

CVS Group PLC is an integrated veterinary services provider. Established in 1999, the company operates a large network of veterinary practices, offering a comprehensive range of clinical services for animals. The group's operations are vertically integrated, encompassing not only primary care and specialist referral practices but also diagnostic laboratories, pet crematoria, and an online retail business. The company focuses on delivering high-quality clinical care and support services across its divisions, with a stated purpose of providing the best possible care to animals.

Recent filings

Filing Released Lang Actions
Trading Update
Earnings Release Classification · 1% confidence The document is titled "Trading Update" and provides key financial highlights (like-for-like sales growth, adjusted EBITDA expectations, net bank borrowings) for the financial year ended 30 June 2022. It explicitly states that the Group expects to announce its preliminary results on a future date (September 22, 2022). This structure—a pre-results update on trading performance—is characteristic of an Earnings Release (ER), which provides initial announcements of periodical financial results (key highlights only), rather than the full comprehensive report (IR) or the final audited results (10-K/AR). It is not a transcript (CT), a presentation (IP), or a formal proxy/governance document. FY 2022
2022-07-28 English
Appointment of Nominated Advisor and Joint Brokers
Regulatory Filings Classification · 1% confidence The document is a formal announcement released via RNS (RNS Number: 2382S) on July 13, 2022. The content announces the appointment of a new Nominated Advisor and Joint Brokers (Peel Hunt LLP and Berenberg) and provides historical director disclosure information as required by AIM Rules for Companies. This type of announcement, which details changes in corporate advisors, board-related disclosures, or other material corporate events not covered by specific financial reporting codes (like 10-K, ER, IR), falls best under the general category for regulatory announcements, which is RNS (Regulatory News Service). It is not a Director's Dealing report (DIRS) as it concerns advisor appointments and historical board disclosures, not current insider trades. It is also not a Management/Board change (MANG) as it focuses on advisors and disclosure compliance rather than a director resignation/appointment.
2022-07-13 English
Block Listing Interim Review and TVR Update
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the 'RNS Number' header and contains specific regulatory updates related to share schemes, block listing review, and total voting rights (TVR). It details the balance of unallotted securities under various employee share schemes and concludes with the total issued share capital and voting rights, which is information required for regulatory disclosure under AIM Rules and FCA Transparency Rules. This type of routine, periodic update concerning share capital structure and employee schemes, disseminated via RNS, fits best under the general 'Regulatory Filings' category, as it is not a primary financial report (10-K, IR), an earnings announcement (ER), or a specific management/board change (MANG/DVA). Given the source (RNS) and the nature of the content (TVR update), RNS is the most appropriate classification.
2022-07-12 English
Conclusion of CMA process, acquisition and trading
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 9258Q' and concludes with boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and compliance with UK MAR. The content announces the conclusion of a CMA process, a recent acquisition (OCVC Limited), and provides a trading update, noting that the full pre-close trading statement will be issued on July 28, 2022, and full-year results on September 22, 2022. Since this is a short announcement (4399 chars) providing updates and referencing future reports, it fits the definition of a general regulatory announcement that doesn't fit a more specific category like ER or IR. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a standard LSE regulatory news service release.
2022-07-01 English
Exercise of Options and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a notification regarding the 'Exercise of Options' resulting in new share issuance and an update to the 'Total Voting Rights'. This type of announcement, which details changes in the total number of shares and voting rights (often used by shareholders for disclosure calculations), is a standard regulatory disclosure in the UK market. Since it is a specific regulatory announcement that doesn't fit the definitions for Dividends (DIV), Share Issue/Capital Change (SHA - which usually relates to a plan or major structural change), or Director's Dealing (DIRS), the most appropriate general category for a routine, mandatory regulatory update provided via RNS is 'Regulatory Filings' (RNS). The document length is short (3609 chars), but it is a primary announcement, not an announcement *about* another report, so RPA is less suitable than RNS for this specific type of mandatory disclosure.
2022-06-30 English
Postponement to Capital Markets Day
Report Publication Announcement Classification · 1% confidence The document is a short announcement disseminated via RNS (Regulatory News Service) from CVS Group plc. The content explicitly states the 'Postponement to Capital Markets Day' which was scheduled for June 22, 2022, and notes it will be rescheduled for the autumn. This is a general corporate announcement regarding an event schedule change, not a specific financial report (like 10-K, IR, ER) or a specific regulatory filing type like Director's Dealing or Major Shareholding. Since it is a general regulatory announcement distributed via RNS that doesn't fit the other specific categories (like AGM-R, CT, DIV, etc.), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (2915 chars) and it is a direct announcement, not an attachment.
2022-06-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.